Philip A. S. Lowden

1.8k citations

23 papers · 1.4k indexed · 1 hit paper · h-index 14

Molecular Biology top 10%
Cellular and Molecular Neuroscience top 5%
Organic Chemistry top 10%
Pharmacology top 5%
Neurology top 10%

Co-authors: Gillian P. Bates Emma Hockly Kirupa Sathasivam Amarbirpal Mahal Donna L. Smith Shabnam Ghazi‐Noori Eddie Rosa Victoria M. Richon
Topics: Microbial Natural Products and Biosynthesis (7 papers)Genetic Neurodegenerative Diseases (5 papers)Chemical Synthesis and Analysis (4 papers)
Cited by: Cellular and Molecular Neuroscience Geriatrics and Gerontology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Angewandte Chemie International Edition
Partner nations: United Kingdom United States Germany

In The Last Decade

Philip A. S. Lowden

23 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

2003 667 citations Emma Hockly, Victoria M. Richon et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Philip A. S. Lowden

Since Specialization

Citations

This map shows the geographic impact of Philip A. S. Lowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. S. Lowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. S. Lowden more than expected).

Fields of papers citing papers by Philip A. S. Lowden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. S. Lowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. S. Lowden. The network helps show where Philip A. S. Lowden may publish in the future.

Co-authorship network of co-authors of Philip A. S. Lowden

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. S. Lowden. A scholar is included among the top collaborators of Philip A. S. Lowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. S. Lowden. Philip A. S. Lowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Crystal Structure of Reduced MsAcg, a Putative Nitroreductase from Mycobacterium smegmatis and a Close Homologue of Mycobacterium tuberculosis Acg 2012 ·Journal of Biological Chemistry ·(unknown),Martin Bommer,Jun Yan,Gary W. Parkin,Tina Daviter,Philip A. S. Lowden,Emma Lloyd Raven,Konstantinos Thalassinos,N.H. Keep	19
2	A Brain-Permeable Small Molecule Reduces Neuronal Cholesterol by Inhibiting Activity of Sirtuin 2 Deacetylase 2011 ·ACS Chemical Biology ·David Taylor,(unknown),Zhongmin Xiang,Ben Woodman,(unknown),Allison Amore,Michele M. Maxwell,Steven A. Reeves,Gillian P. Bates,Ruth Luthi‐Carter,Philip A. S. Lowden,Aleksey Kazantsev	115
3	Detection of a single DNA base-pair mismatch using an anthracene-tagged fluorescent probe 2006 ·Chemical Communications ·(unknown),Dario M. Bassani,Jean‐Pierre Desvergne,Sonja Keiper,Philip A. S. Lowden,Joseph S. Vyle,James H. R. Tucker	32
4	Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease 2005 ·Neurobiology of Disease ·Emma Hockly,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Hilary Moffitt,Kirupa Sathasivam,(unknown),Erich E. Wanker,Philip A. S. Lowden,Gillian P. Bates	60
5	Biosynthetic studies on the azinomycins: The pathway to the naphthoate fragment 2004 ·Chemical Communications ·Christophe Corre,(unknown),Michael Shipman,Philip A. S. Lowden	13
6	The first biosynthetic studies of the azinomycins: acetate incorporation into azinomycin BElectronic supplementary information (ESI) available: experimental procedures for fermentation of S. sahachiroi and isolation of azinomycin B, NMR data from labeling experiments. See http://www.rsc.org/suppdata/cc/b4/b400093e/ 2004 ·Chemical Communications ·Christophe Corre,Philip A. S. Lowden	19
7	Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's diseasebreakdown → 2003 ·Proceedings of the National Academy of Sciences ·Emma Hockly,Victoria M. Richon,(unknown),Donna L. Smith,Xianbo Zhou,Eddie Rosa,Kirupa Sathasivam,Shabnam Ghazi‐Noori,Amarbirpal Mahal,Philip A. S. Lowden,Joan S. Steffan,Joan Marsh,Leslie M. Thompson,Cathryn M. Lewis,Paul A. Marks,Gillian P. Bates	667
8	Minocycline and doxycycline are not beneficial in a model of Huntington's disease 2003 ·Annals of Neurology ·Donna L. Smith,(unknown),Amarbirpal Mahal,Kirupa Sathasivam,Shabnam Ghazi‐Noori,Philip A. S. Lowden,Gillian P. Bates,Emma Hockly	131
9	Electrochemical, in vitro and cell culture analysis of integrated redox catalysts: implications for cancer therapy 2003 ·Chemical Communications ·Gregory I. Giles,Niroshini M. Giles,(unknown),(unknown),F.H. Fry,Philip A. S. Lowden,Nicholas J. Gutowski,Claus Jacob	30
10	Reply 2003 ·Annals of Neurology ·Emma Hockly,(unknown),Philip A. S. Lowden,Gillian P. Bates	2
11	Origin and True Nature of the Starter Unit for the Rapamycin Polyketide Synthase 2001 ·Angewandte Chemie ·Philip A. S. Lowden,Barrie Wilkinson,Günter A. Böhm,Sandeep Handa,Heinz G. Floss,Peter F. Leadlay,James Staunton	10
12	Chemical biology 2001 ·Current Opinion in Chemical Biology ·Lisa Matthews,Muneesh Tewari,Nicola L. B. Pohl,Richard Cammack,Dennis G. Hall,Steven J. Projan,Tony Cass,Jon D. Stewart,Jeremy K. M. Sanders,Sarah C. M. Roberts,Sabine L. Flitsch,Philip A. S. Lowden,Richard Newman	1
13	Origin and True Nature of the Starter Unit for the Rapamycin Polyketide Synthase 2001 ·Angewandte Chemie International Edition ·Philip A. S. Lowden,Barrie Wilkinson,Günter A. Böhm,Sandeep Handa,Heinz G. Floss,Peter F. Leadlay,James Staunton	37
14	Chemical biology 2001 ·Current Opinion in Chemical Biology ·Lisa Matthews,Muneesh Tewari,Nicola L. B. Pohl,Richard Cammack,Dennis G. Hall,Steven J. Projan,Jon D. Stewart,Sarah Roberts,Jeremy K. M. Sanders,Sabine L. Flitsch,Philip A. S. Lowden,Richard Newman	2
15	Chemical biology 2000 ·Current Opinion in Chemical Biology ·M. Morgan Conn,(unknown),Nicola L. B. Pohl,Richard Cammack,Dennis G. Hall,Steven J. Projan,Tony Cass,Jon D. Stewart,Sabine L. Flitsch,Philip A. S. Lowden,Richard Newman	7
16	Chemical biology 1999 ·Current Opinion in Chemical Biology ·Dale G. Drueckhammer,Richard Cammack,David L. Pompliano,Tony Cass,Jon D. Stewart,Graham R. L. Cousins,Yolanda R. de Miguel,Jeremy K. M. Sanders,Sabine L. Flitsch,Philip A. S. Lowden,Gary J. Pielak	7
17	The Pipecolate‐Incorporating Enzyme for the Biosynthesis of the Immunosuppressant Rapamycin — Nucleotide Sequence Analysis, Disruption and Heterologous Expression of Rap P from Streptomyces Hygroscopicus 1997 ·European Journal of Biochemistry ·Ariane König,Torsten Schwecke,(unknown),Günter A. Böhm,Philip A. S. Lowden,James Staunton,Peter F. Leadlay	61
18	Enzyme-catalyzed formation of glycosidic linkages 1997 ·Current Opinion in Structural Biology ·Gregory M. Watt,Philip A. S. Lowden,Sabine L. Flitsch	44
19	The Nature of the Starter Unit for the Rapamycin Polyketide Synthase 1996 ·Angewandte Chemie International Edition in English ·Philip A. S. Lowden,Günter A. Böhm,James Staunton,Peter F. Leadlay	26
20	Die Startereinheit der Rapamycin‐Polyketid‐Synthase 1996 ·Angewandte Chemie ·Philip A. S. Lowden,Günter A. Böhm,James Staunton,Peter F. Leadlay	8

About Philip A. S. Lowden

Philip A. S. Lowden is a scholar working on Toxicology, Pharmacology and Organic Chemistry, having authored 23 papers that have together received 1.4k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (7 papers), Genetic Neurodegenerative Diseases (5 papers) and Chemical Synthesis and Analysis (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (527 citations), Geriatrics and Gerontology (99 citations) and Molecular Biology (966 citations). Philip A. S. Lowden has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Gillian P. Bates, Emma Hockly, Kirupa Sathasivam, Amarbirpal Mahal, Donna L. Smith, Shabnam Ghazi‐Noori, Eddie Rosa, Victoria M. Richon, Xianbo Zhou and Leslie M. Thompson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact